Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption

Detalles Bibliográficos
Autores principales: Demeter, Judit, Weisinger, Julia, Nagy, Zsolt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938919/
https://www.ncbi.nlm.nih.gov/pubmed/33747403
http://dx.doi.org/10.4084/MJHID.2021.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938919/
https://www.ncbi.nlm.nih.gov/pubmed/33747403
http://dx.doi.org/10.4084/MJHID.2021.022

Ejemplares similares